The 'Pinhole' Cancer Treatment You've Probably Never Heard of

Imagine an exquisitely precise cancer therapy procedure done through a small opening in the body that can: Kill tumor cells, shrink tumors, or regrow the healthy part of a cancerous organ. Deliver chemotherapy or radiation directly to the cancer site. Usually be done as an outpatient procedure with fewer side effects than conventional treatments like chemotherapy. Potentially treat many types of cancer, either alone or combined with other therapies. Sounds too good to be true, right? Not necessarily, since this type of therapy, called interventional oncology, is now being performed hundreds of times every day by specialists in a medical field that is unfamiliar to many cancer patients. Many predict this fast-growing specialty will soon join medical, surgical and radiation oncology as the fourth pillar of cancer care. Pioneers in Precision Medicine Interventional oncology is an image-guided, minimally invasive surgery done by radiologists that uses imaging scans as maps to identify the location of tumors and blood vessels as pathways to kill tumors or shrink and prepare them for removal. Most procedures are either outpatient or require a brief overnight stay in the hospital. Recovery time is minimal; some patients are active as early as the next day. Plus, there are rarely the physical complications associated with surgery nor the side effects with chemotherapy or external radiation, like hair loss. Interventional oncology is a subset of the field of interventional radiolog...
Source: Science - The Huffington Post - Category: Science Source Type: news

Related Links:

CONCLUSIONS: It was found that most patients diagnosed with breast cancer showed dermatologic manifestations during the proposed cancer treatment. Patients undergoing radiotherapy and surgery showed skin changes with greater statistical significance.
Source: Anais Brasileiros de Dermatologia - Category: Dermatology Source Type: research
AbstractThe increased survival of breast cancer (BC) patients by earlier detection and improved treatment outcomes together with younger age at diagnosis, raised the concerns about Quality Of Life among survivors, suffering from treatment side effects. To measure QOL among BC Egyptian females, then to compare HRQOL scores in BC patients receiving different lines of treatment. A comparative cross-sectional study on a sample 142  BC survivor receiving different lines of treatment, using EORTC QLQ-C30, and a BC-specific scale (QLQBR23 scale). The emotional functioning had the lowest score (29.22 ± 8....
Source: Journal of Community Health - Category: International Medicine & Public Health Source Type: research
Conclusion: Kangai injection as an adjuvant method in combination with chemotherapy for treating Chinese breast cancer patients can improve their life quality and physical conditions and reduce the adverse reactions that result from chemotherapy. However, the present conclusion is only suitable for the Chinese population. The long-term, high-quality researches are required to further verify the above conclusions. PMID: 29849714 [PubMed]
Source: Evidence-based Complementary and Alternative Medicine - Category: Complementary Medicine Tags: Evid Based Complement Alternat Med Source Type: research
Journal of the European Academy of Dermatology and Venereology, EarlyView.
Source: Journal of the European Academy of Dermatology and Venereology - Category: Dermatology Authors: Source Type: research
CONCLUSIONS: Individual evaluation and appropriate explanation is significant to further children's understanding of their mother's illness. Future studies with larger sample size are needed to explore the understanding for children of different ages, in order to provide specific help for these children. PMID: 29784143 [PubMed - in process]
Source: European Journal of Oncology Nursing - Category: Nursing Authors: Tags: Eur J Oncol Nurs Source Type: research
In this study, we first investigated cognitive impairment resulting from trastuzumab therapy, and investigated the mitigation of this impairment following atorvastatin treatment with respect to cerebral glucose metabolism and regional gray matter concentration. In addition, enhanced accumulation of trastuzumab in tumors after atorvastatin treatment was assessed using a HER2-positive gastric cancer model. Methods: Cognitive deficit was modeled using BALB/nude mice, and alopecia was modeled using C57BL/6 mice; 150 μg of trastuzumab (I.V.) and 20 mg/kg of atorvastatin (I.P.) were administrated to observe the effect of this...
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Tags: Technical Advances in Clinical Assessment of Soild Tumors Source Type: research
If you have mesothelioma and you’ve already received standard-of-care therapies, you may be considering an immunotherapy clinical trial. If you’re considering this option, a free immunotherapy teleconference is a great place to learn more. CancerCare recently hosted two one-hour education workshops featuring panels of immunotherapy experts. Part I of the teleconference presented an overview of immunotherapy. Part II of the teleconference, which is available online for free, focused exclusively on immunotherapy side effects. Understanding these issues and the role each patient plays in managing their own side ef...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
We report a complex case of PCT in a 67-year-old woman with an unusual constellation of cutaneous findings: scleroderma, acquired ichthyosis, and nonscarring alopecia. Possible triggers for her PCT include tamoxifen treatment for breast cancer and carrier status of the hemochromatosis gene. High-dose chloroquine was used to successfully achieve clinical remission and normalize her uroporphyrins. While on chloroquine she developed extensive classic vitiligo. It is not clear if this is another feature of her complex and unusual PCT, or a consequence of her antimalarial therapy.Case Rep Dermatol 2018;10:115 –121
Source: Case Reports in Dermatology - Category: Dermatology Source Type: research
CONCLUSIONS: In patients nearing the end of life, there are significant associations between disease and treatment related symptoms and unmet patient needs, which do not change substantially over time. Careful exploration of specific end-of-life care needs can improve patient-centered care and QOL. PMID: 29778506 [PubMed - as supplied by publisher]
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Tags: Gynecol Oncol Source Type: research
Opinion statementAnthracycline-based regimens have been an important treatment component for patients with breast cancer. As demonstrated in the last Early Breast Cancer Trialists ’ Collaborative Group (EBCTCG) meta-analysis, anthracycline-based regimens decrease breast cancer mortality by 20–30%. Anthracycline toxicities include the rare—but potential morbid—cardiotoxicity or leukemogenic effect, and the almost universal—but very distressing—alopecia. Due to pote ntial toxicities, and large number of patients being exposed, several worldwide trials have re-examined the role of anthracyc...
Source: Current Treatment Options in Oncology - Category: Cancer & Oncology Source Type: research
More News: Alopecia | Cancer | Cancer & Oncology | Cancer Therapy | Chemotherapy | Education | External Beam Therapy | Government | Health | Hospitals | Immunotherapy | Insurance | Insurers | Liver | Medical Devices | Minimally Invasive Surgery | PET Scan | Radiology | Science | Universities & Medical Training | Urology & Nephrology | Websites